• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用贝叶斯统计决策标准降低临床前动物研究的错误发现率。

Reducing the false discovery rate of preclinical animal research with Bayesian statistical decision criteria.

作者信息

Kelter Riko

机构信息

Department of Mathematics, University of Siegen, Germany.

出版信息

Stat Methods Med Res. 2023 Oct;32(10):1880-1901. doi: 10.1177/09622802231184636. Epub 2023 Jul 31.

DOI:10.1177/09622802231184636
PMID:37519294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10563376/
Abstract

The success of preclinical research hinges on exploratory and confirmatory animal studies. Traditional null hypothesis significance testing is a common approach to eliminate the chaff from a collection of drugs, so that only the most promising treatments are funneled through to clinical research phases. Balancing the number of false discoveries and false omissions is an important aspect to consider during this process. In this paper, we compare several preclinical research pipelines, either based on null hypothesis significance testing or based on Bayesian statistical decision criteria. We build on a recently published large-scale meta-analysis of reported effect sizes in preclinical animal research and elicit a non-informative prior distribution under which both approaches are compared. After correcting for publication bias and shrinkage of effect sizes in replication studies, simulations show that (i) a shift towards statistical approaches which explicitly incorporate the minimum clinically important difference reduces the false discovery rate of frequentist approaches and (ii) a shift towards Bayesian statistical decision criteria can improve the reliability of preclinical animal research by reducing the number of false-positive findings. It is shown that these benefits hold while keeping the number of experimental units low which are required for a confirmatory follow-up study. Results show that Bayesian statistical decision criteria can help in improving the reliability of preclinical animal research and should be considered more frequently in practice.

摘要

临床前研究的成功取决于探索性和确证性动物研究。传统的零假设显著性检验是从一系列药物中筛选出有效药物的常用方法,这样只有最有前景的治疗方法才能进入临床研究阶段。在此过程中,平衡假阳性发现和假阴性遗漏的数量是一个需要考虑的重要方面。在本文中,我们比较了几种临床前研究流程,这些流程要么基于零假设显著性检验,要么基于贝叶斯统计决策标准。我们基于最近发表的一项对临床前动物研究中报告的效应量的大规模荟萃分析,并引出一种无信息先验分布,在此分布下对两种方法进行比较。在对复制研究中的发表偏倚和效应量收缩进行校正后,模拟结果表明:(i)转向明确纳入最小临床重要差异的统计方法可降低频率主义方法的假阳性发现率;(ii)转向贝叶斯统计决策标准可通过减少假阳性发现的数量来提高临床前动物研究的可靠性。结果表明,在确证性后续研究所需的实验单元数量较少的情况下,这些益处依然存在。结果表明,贝叶斯统计决策标准有助于提高临床前动物研究的可靠性,在实践中应更频繁地予以考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10563376/d4c38455968a/10.1177_09622802231184636-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10563376/e9e0fe336296/10.1177_09622802231184636-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10563376/bbc199cf8df5/10.1177_09622802231184636-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10563376/384cd2c2bffa/10.1177_09622802231184636-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10563376/eaaee8b72ff8/10.1177_09622802231184636-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10563376/bc213dd74ed0/10.1177_09622802231184636-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10563376/d4c38455968a/10.1177_09622802231184636-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10563376/e9e0fe336296/10.1177_09622802231184636-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10563376/bbc199cf8df5/10.1177_09622802231184636-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10563376/384cd2c2bffa/10.1177_09622802231184636-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10563376/eaaee8b72ff8/10.1177_09622802231184636-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10563376/bc213dd74ed0/10.1177_09622802231184636-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/10563376/d4c38455968a/10.1177_09622802231184636-fig6.jpg

相似文献

1
Reducing the false discovery rate of preclinical animal research with Bayesian statistical decision criteria.使用贝叶斯统计决策标准降低临床前动物研究的错误发现率。
Stat Methods Med Res. 2023 Oct;32(10):1880-1901. doi: 10.1177/09622802231184636. Epub 2023 Jul 31.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Worked-out examples of the adequacy of Bayesian optional stopping.贝叶斯可选择性中止充分性的实例研究。
Psychon Bull Rev. 2022 Feb;29(1):70-87. doi: 10.3758/s13423-021-01962-5. Epub 2021 Jul 12.
4
Patient-Centered Clinical Trial Design for Heart Failure Devices via Bayesian Decision Analysis.基于贝叶斯决策分析的心力衰竭器械以患者为中心的临床试验设计。
Patient. 2023 Jul;16(4):359-369. doi: 10.1007/s40271-023-00623-0. Epub 2023 Apr 19.
5
Bayesian lesion-deficit inference with Bayes factor mapping: Key advantages, limitations, and a toolbox.基于贝叶斯因子映射的贝叶斯病变-缺损推断:主要优势、局限性及一个工具箱
Neuroimage. 2023 May 1;271:120008. doi: 10.1016/j.neuroimage.2023.120008. Epub 2023 Mar 11.
6
Providing Evidence for the Null Hypothesis in Functional Magnetic Resonance Imaging Using Group-Level Bayesian Inference.使用组水平贝叶斯推理为功能磁共振成像中的零假设提供证据。
Front Neuroinform. 2021 Dec 2;15:738342. doi: 10.3389/fninf.2021.738342. eCollection 2021.
7
Practical Bayesian Inference in Neuroscience: Or How I Learned To Stop Worrying and Embrace the Distribution.神经科学中的实用贝叶斯推理:或者说我是如何学会不再担忧并接受分布的。
bioRxiv. 2024 Mar 7:2023.11.19.567743. doi: 10.1101/2023.11.19.567743.
8
Can testing clinical significance reduce false positive rates in randomized controlled trials? A snap review.检测临床意义能否降低随机对照试验中的假阳性率?简要综述。
BMC Res Notes. 2017 Dec 28;10(1):775. doi: 10.1186/s13104-017-3117-4.
9
Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.基于二次损失函数的贝叶斯决策理论组序贯临床试验设计:频率学派评估
Clin Trials. 2007;4(1):5-14. doi: 10.1177/1740774506075764.
10
Bayesian evaluation of informative hypotheses in cluster-randomized trials.贝叶斯评价在整群随机试验中信息性假设。
Behav Res Methods. 2019 Feb;51(1):126-137. doi: 10.3758/s13428-018-1149-x.

本文引用的文献

1
Bayesian approaches to designing replication studies.设计重复研究的贝叶斯方法。
Psychol Methods. 2023 Aug 10. doi: 10.1037/met0000604.
2
The evidence interval and the Bayesian evidence value: On a unified theory for Bayesian hypothesis testing and interval estimation.证据区间与贝叶斯证据值:关于贝叶斯假设检验与区间估计的统一理论
Br J Math Stat Psychol. 2022 Nov;75(3):550-592. doi: 10.1111/bmsp.12267. Epub 2022 Mar 1.
3
Sample size planning for replication studies: The devil is in the design.复制研究的样本量规划:魔鬼在设计中。
Psychol Methods. 2024 Oct;29(5):844-867. doi: 10.1037/met0000520. Epub 2022 Jul 21.
4
Beyond < .05: a critical review of new Bayesian proposals for assessing the -value.超越<.05:对用于评估P值的新贝叶斯方法的批判性综述
J Biopharm Stat. 2022 Mar;32(2):308-329. doi: 10.1080/10543406.2021.2009497. Epub 2022 Mar 4.
5
Reverse-Bayes methods for evidence assessment and research synthesis.逆贝叶斯方法在证据评估和研究综合中的应用。
Res Synth Methods. 2022 May;13(3):295-314. doi: 10.1002/jrsm.1538. Epub 2021 Dec 30.
6
Investigating the replicability of preclinical cancer biology.探究癌症生物学的临床前可重复性。
Elife. 2021 Dec 7;10:e71601. doi: 10.7554/eLife.71601.
7
Decisions about equivalence: A comparison of TOST, HDI-ROPE, and the Bayes factor.关于等效性的决策:TOST、HDI-ROPE 和贝叶斯因子的比较。
Psychol Methods. 2023 Jun;28(3):740-755. doi: 10.1037/met0000402. Epub 2021 Nov 4.
8
How to Choose between Different Bayesian Posterior Indices for Hypothesis Testing in Practice.在实际的假设检验中,如何在不同的贝叶斯后验指标之间进行选择。
Multivariate Behav Res. 2023 Jan-Feb;58(1):160-188. doi: 10.1080/00273171.2021.1967716. Epub 2021 Sep 28.
9
fbst: An R package for the Full Bayesian Significance Test for testing a sharp null hypothesis against its alternative via the e value.fbst:一个 R 包,用于全贝叶斯显著性检验,通过 e 值对尖锐零假设与其备择假设进行检验。
Behav Res Methods. 2022 Jun;54(3):1114-1130. doi: 10.3758/s13428-021-01613-6. Epub 2021 Sep 1.
10
Bayesian Hodges-Lehmann tests for statistical equivalence in the two-sample setting: Power analysis, type I error rates and equivalence boundary selection in biomedical research.贝叶斯霍奇斯-莱曼检验在两样本设置中的统计等效性:生物医学研究中的功效分析、Ⅰ类错误率和等效边界选择。
BMC Med Res Methodol. 2021 Aug 17;21(1):171. doi: 10.1186/s12874-021-01341-7.